查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540849

2024-2032 年按產品類型、製造技術、分析方法、應用、最終用戶和地區分類的生物晶片市場報告

Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球生物晶片市場規模達196億美元。在下一代定序和晶片實驗室技術創新以增強生物晶片能力、政府和私營部門為遺傳和分子研究提供大量資金以及對個人化醫療日益成長的需求的推動下，該市場正在經歷穩定成長。

生物晶片市場分析：

主要市場驅動力：生物晶片技術的技術進步和後續創新極大地推動了市場。此外，靈敏度、精度和小型化的提高也推動了對這些晶片的需求。市場的其他重要促進因素包括對個人化醫療的需求不斷成長以及對基因組學和蛋白​​質組學研究的投資增加。

主要市場趨勢：生物晶片技術與人工智慧和機器學習演算法的整合就是這樣的主要趨勢之一。它正在促進精準醫學、藥物發現和診斷的發展，並提高準確性。這可以透過將個人化和預防性治療模式轉向採用生物晶片進行高度詳細的分子分析和有針對性的治療介入來支持。

地理趨勢：根據生物晶片市場研究報告，由於醫療保健和生物技術研究的大量投資，北美生物晶片市場佔有率不斷增加。受中國和印度等國家醫療保健支出增加以及對精準醫療日益關注的推動，亞太地區正在快速成長。

競爭格局：市場競爭非常激烈，主要參與者正在投資研發，為市場提供平台創新。同時，主要參與者正在進行策略合作、合併和收購，以在技術專長和地理影響力方面佔據優勢。生物晶片產業的一些主要市場參與者包括 Agilent Technologies, Inc.、bioMerieux SA、Bio-RAD Laboratories, Inc.、CapitalBio Corporation、Dynamic Biosensors GmbH、EMD Millipore Corporation、Fluidigm Corporation、Illumina, Inc.、Perkinelmer, Inc. .、Thermo Fisher Scientific Inc. 等。

挑戰與機會：與生物晶片技術相關的高成本以及監管框架（特別是在某些國家）很複雜，因此該市場的成長面臨重大挑戰。機會在於生物晶片在農業、法醫學、環境監測等快速發展領域的應用延伸，以及生物晶片技術的不斷發展。

生物晶片市場趨勢：

技術進步與創新

技術的快速進步和生物晶片技術的定期修改推動了市場。生物晶片正在發生變革，例如下一代定序 (NGS)、晶片實驗室和微陣列技術可提高生物晶片的功率和有效性。此外，與人工智慧 (AI) 和機器學習 (ML) 演算法整合的基於生物晶片的解決方案的出現正在擴大精準醫療、藥物發現和診斷相關的應用。隨著生物晶片向基因組學、蛋白質組學和其他分子生物學領域提高靈敏度、準確性和小型化方向發展，生物晶片正在成為必不可少的工具，這提高了生物晶片的市場價值。此外，知名產業參與者在研發方面不斷採取舉措，推出先進的生物晶片產品和解決方案，以有效應對醫療保健和生物技術垂直領域的新興需求，進一步推動市場擴張。

個人化醫療需求不斷成長

對個人化醫療的需求不斷成長也大大推動了市場的發展。個人化醫療是一種根據遺傳、環境和生活方式因素對患者進行個別分析來製定治療計劃的實踐，正在加速對生物晶片相關技術的需求。此外，隨著醫療保健產業迅速轉向個人化和預防性醫療，對生物晶片等先進診斷工具的需求也不斷成長。癌症和心血管疾病等慢性疾病發生率的增加也支持了這一趨勢，這些疾病需要詳細的分子洞察才能進行有效的管理。因此，由於個人化醫療範圍不斷擴大，生物晶片在臨床和研究環境中繼續獲得更大的接受度，這進一步創造了積極的生物晶片市場前景。

增加基因組學和蛋白​​質組學研究的投資

全球生物晶片市場的關鍵驅動力之一是增加對基因組和蛋白質組研究的投資。所有政府、學術機構和私營部門都在投資基因組和蛋白質組研究，以了解複雜的生物系統並設計創新的健康解決方案。生物晶片具有廣泛的應用，因為它們允許對各種相互作用（例如遺傳或蛋白質組學）進行高通量分析和大規模研究。此外，精準農業、法醫科學和環境監測等領域的應用日益成長，這些領域都需要高通量分子分析。此外，隨著全球不斷成長的資金和合作研究不斷擴大該市場的範圍，對複雜生物晶片平台的需求正在上升，從而引導其促進正在進行的新生命科學研究。

生物晶片市場細分：

IMARC Group提供了全球生物晶片市場報告各細分市場主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品類型、製造技術、分析方法、應用和最終用戶對市場進行了分類。

按產品類型分類：

DNA晶片

蛋白質晶片

晶片實驗室

酵素晶片

DNA 晶片代表最大的細分市場

該報告根據產品類型對生物晶片市場進行了詳細的細分和分析。這包括 DNA 晶片、蛋白質晶片、晶片實驗室和酵素晶片。報告稱，DNA 晶片是最大的細分市場。

DNA 晶片，也稱為 DNA 微陣列，是目前市場上最大的產品類型。廣泛的應用範圍和技術進步可以支持這一點。這些晶片有助於對遺傳資訊進行大規模分析；此類晶片成為基因組學、診斷和個人化醫療的核心工具。可以同時分析數千個基因，從而使癌症基因組學、遺傳性疾病篩檢和藥物基因組學相關的研究發生了里程碑式的變化。它透過升級技術生產出更靈敏、更特異、更有效率的 DNA 晶片，從而提高了採用率。根據生物晶片市場報告，個人基因體學對精準醫療和健康療法的興趣日益濃厚，也加速了對 DNA 晶片的需求。市場上的主要參與者正在進行廣泛的研究和開發，以推出 DNA 晶片新產品，從而幫助滿足醫療保健和生物技術公司不斷變化的需求。除此之外，遺傳性疾病和慢性疾病發生率的增加需要詳細的基因分析，因此 DNA 晶片在當代診斷和治療中發揮重要作用。因此，DNA 晶片在生物晶片市場中佔有更大的佔有率，因為它們是促進分子生物學和個人醫療保健解決方案的重要組成部分。

依製造技術分解：

微陣列

微流控

微陣列代表最大的細分市場

報告還根據製造技術對生物晶片市場進行了詳細的細分和分析。這包括微陣列和微流體。報告稱，微陣列佔據了最大的市場佔有率。

微陣列技術因其針對不同應用的多功能性和效率而成為該市場中使用最廣泛的製造技術。此方法允許同時分析大量生物資料，並用於基因組學、轉錄組學和蛋白​​質組學研究。生物晶片市場預測表明，在一次實驗中對整個譜系的基因或蛋白質表現進行量化對於藥物發現、疾病診斷和個人化醫療將改變遊戲規則。新的微陣列技術支援更準確、更快速和規模化的生物晶片製造，從而能夠對大部分相應用戶群體進行可靠檢測。微陣列技術廣泛應用於醫療保健和生物資訊學領域，以改善研究活動，並幫助引入新的標靶療法。此外，它們與現代資料分析技術和生物資訊學平台的整合進一步擴大了微陣列在理解複雜生物過程方面的用途。隨著個人化醫療的發展，未來幾年對微陣列等準確、高通量分析平台的需求將大幅增加。因此，微陣列技術仍然是市場上領先的製造方法，並在推動生物醫學研究向前發展以及改善臨床診斷方面發揮基礎性作用。

依分析方法細分：

電泳

發光

質譜分析

電訊號

磁性

電泳代表最大的細分市場

報告還根據分析方法對生物晶片市場進行了詳細的細分和分析。這包括電泳、發光、質譜、電訊號和磁性。報告稱，電泳佔據最大的市場佔有率。

電泳因其在分離技術和生物分子分析中的廣泛適用性、強度和精度而成為生物晶片中最主要的分析方法。這也代表了功能基因組學、蛋白質組學和分子生物學中的一項重要技術，透過根據大小和電荷有效分離 DNA、RNA 和蛋白質，從而了解它們的結構和功能。根據生物晶片市場概況，電泳正在多個研究和常規實驗室中使用，特別是在與基因圖譜、疾病診斷和法醫分析相關的任務中。除了是一個強大而準確的系統之外，它還可以與先進的生物晶片技術協同工作，以確保分子分析具有更好的解析度和更高的通量。電泳技術（包括毛細管電泳和微流體電泳）最近進行了創新，以進一步增強其操作、速度更快並提供更詳細的檢查。個人化醫療和生物技術領域對高精度分析工具的需求不斷成長，電泳將繼續佔據主導地位。此外，隨著複雜的生物系統和疾病機制的不斷升級，它鞏固了作為市場領先分析方法的核心地位。

按應用分類：

分子分析

雜交

蛋白質

免疫學

生物分子

生物標記

其他

診斷

基因診斷

腫瘤學

發炎

其他

非生物用途

診斷代表最大的細分市場

報告還根據應用對生物晶片市場進行了詳細的細分和分析。這包括分子分析（雜交、蛋白質、免疫學、生物分子、生物標記等）、診斷（基因診斷、腫瘤學、發炎等）和非生物學用途。報告顯示，診斷佔最大的市場佔有率。

診斷是市場上最大的應用，因為醫療保健中需要準確、快速且全面的診斷工具。生物晶片正在徹底改變診斷概念，因為它們可以在單一晶片中分析多種生物標記物，有助於早期、準確地檢測疾病。因此，這正在不斷增加生物晶片的需求。這對於治療癌症、心血管疾病和新出現的病毒感染等慢性疾病和傳染病非常重要。這些因素導致生物晶片整合到診斷平台中，進一步提高了測試的特異性和敏感性，從而根據測試結果，透過及時和有針對性的干涉措施，帶來更好的患者結果。除此之外，以微陣列和晶片實驗室系統形式出現的生物晶片技術的進步使得診斷層面的事情變得更簡單、更具成本效益且更容易獲得。個人化醫療的興起進一步提高了基於生物晶片的診斷的風險，因為這些將能夠對基因圖譜進行分析，以根據個體進行治療。隨著全球醫療保健格局向精準和預防醫學的方向不斷變化，用於診斷目的的生物晶片的採用正在獲得相當大的普及，這實質上將其作為現代醫療診斷的基石，並推動了生物晶片市場的成長。

按最終用戶分類：

製藥和生物技術公司

醫院和診斷中心

學術及研究機構

其他

製藥和生物技術公司代表最大的市場領域

報告還提供了基於最終用戶的生物晶片市場的詳細細分和分析。這包括製藥和生物技術公司、醫院和診斷中心、學術和研究機構等。報告顯示，製藥和生物技術公司佔據了最大的市場。

生物晶片產業最大的最終用戶是製藥和生物技術公司。這可以歸因於他們廣泛的研究和開發活動以及藥物發現和開發過程中對新解決方案的需求增加。生物晶片在高通量篩選、基因分析和生物標記識別等領域為這些領域提供了巨大幫助，以了解疾病機制和隨後開發標靶治療。此外，生物晶片技術使新的技術精確、更快、更便宜的方法成為可能，加速藥物開發，並為臨床試驗的規劃提供資訊和便利，從而透過詳細的分子洞察將個人化醫療付諸實踐。對此，研究企業對生物晶片技術的大量投資是為了提高效率並降低開發成本。此外，生物晶片製造商與製藥和生物技術公司之間的密切合作促進了針對特殊研究需求的進一步改進的生物晶片形式。隨著對新療法和個人化治療方案的需求不斷成長帶來的持續壓力，這些行業對生物晶片的依賴越來越大，它可以在創新和建立競爭優勢以應對不斷變化的醫療保健環境方面產生關鍵差異。

按地區分類：

北美洲

美國

加拿大

歐洲

德國

法國

英國

西班牙

俄羅斯

義大利

其他

亞太地區

中國

日本

印度

韓國

澳洲

其他

拉丁美洲

墨西哥

巴西

阿根廷

其他

中東和非洲

土耳其

沙烏地阿拉伯

阿拉伯聯合大公國

其他

北美市場領先，佔據最大的生物晶片市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、西班牙、俄羅斯、義大利等）；亞太地區（中國、印度、日本、韓國、澳洲等）；拉丁美洲（墨西哥、巴西、阿根廷等）；以及中東和非洲（土耳其、沙烏地阿拉伯、阿拉伯聯合大公國等）。報告稱，北美是生物晶片最大的區域市場。

由於高品質的醫療基礎設施和對生物技術研究的大量投資，北美地區是生物晶片市場的最大貢獻者，其次是受到技術創新強勁推動的亞太地區。此外，該地區的主權也受到生物技術領域一些主要市場參與者的推動，例如三星生物製品公司和Celltrion，以及政府對研發活動的全面支持。同時，不斷成長的慢性疾病和個人化醫療需求進一步推動了生物晶片技術的使用增加。由於基因組學和蛋白​​質組學研究撥款增加了生物晶片市場收入，美國和加拿大等主要國家的該市場的潛在成長機會正在推動區域擴張。此外，北美成熟的製藥和生物技術產業的存在使得生物晶片應用能夠在不同的醫療保健環境中快速商業化和採用。

本報告回答的關鍵問題：

  • 迄今為止，全球生物晶片市場表現如何，未來幾年將如何表現？
  • 全球生物晶片市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球生物晶片市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的生物晶片市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 生物晶片市場上最具吸引力的產品類型是什麼？
  • 基於製造技術的市場區隔是什麼？
  • 生物晶片市場上最具吸引力的製造技術是什麼？
  • 根據分析方法，市場的細分是什麼？
  • 生物晶片市場上最具吸引力的分析方法是什麼？
  • 基於應用的市場區隔是什麼？
  • 生物晶片市場最有吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 生物晶片市場上最有吸引力的最終用戶是誰？
  • 市場競爭結構如何？
  • 誰是全球生物晶片市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物晶片市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • DNA晶片
    • 市場趨勢
    • 市場預測
  • 蛋白質晶片
    • 市場趨勢
    • 市場預測
  • 晶片實驗室
    • 市場趨勢
    • 市場預測
  • 酵素晶片
    • 市場趨勢
    • 市場預測

第 7 章：市場細分：依製造技術

  • 微陣列
    • 市場趨勢
    • 市場預測
  • 微流控
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按分析方法

  • 電泳
    • 市場趨勢
    • 市場預測
  • 發光
    • 市場趨勢
    • 市場預測
  • 質譜分析
    • 市場趨勢
    • 市場預測
  • 電訊號
    • 市場趨勢
    • 市場預測
  • 磁性
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按應用

  • 分子分析
    • 雜交
      • 市場趨勢
      • 市場預測
    • 蛋白質
      • 市場趨勢
      • 市場預測
    • 免疫學
      • 市場趨勢
      • 市場預測
    • 生物分子
      • 市場趨勢
      • 市場預測
    • 生物標記
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 診斷
    • 基因診斷
      • 市場趨勢
      • 市場預測
    • 腫瘤學
      • 市場趨勢
      • 市場預測
    • 發炎
      • 市場趨勢
      • 市場預測
    • 其他
      • 市場趨勢
      • 市場預測
  • 非生物用途
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測
  • 醫院和診斷中心
    • 市場趨勢
    • 市場預測
  • 學術及研究機構
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 俄羅斯
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: SR112024A2741

The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The market is experiencing steady growth driven by innovations in next-generation sequencing and lab-on-a-chip technologies to enhance biochip capabilities, substantial funding from governments and private sectors for genetic and molecular research, and the increasing demand for personalized medicine.

Biochips Market Analysis:

Major Market Drivers: Advances in technology and subsequent innovations in the technology of biochips greatly fuel the market. Additionally, the rise in sensitivity, accuracy, and miniaturization is also driving the demand for these chips. Other prominent drivers for the market include rising demand for personalized medicine and augmented investment in genomics and proteomics research.

Key Market Trends: The integration of biochip technology with AI and ML algorithms is one such key trend. It is facilitating the development of precision medicine, drug discovery, and diagnostics with enhanced accuracy. This can be supported by shifting personalized and preventive treatment patterns towards the adoption of biochips for highly detailed molecular analyses and targeted therapeutic interventions.

Geographical Trends: According to the biochips market research report, North America represents an increasing biochips market share driven by heavy investment in health care and biotechnology research. Asia-Pacific is rapidly growing, impelled by increasing expenditure on healthcare and a rising focus on precision medicine in countries such as China and India.

Competitive Landscape: The market is quite a competitive space where key players are investing in research and development to offer platform innovations into the market. Concurrently, the major players are entering strategic collaborations, mergers, and acquisitions to get an upper hand on technological expertise and geographical presence. Some of the major market players in the biochips industry include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: The high cost associated with biochip technology, and the regulatory framework, particularly in certain countries, is complex, hence the major challenges to the growth of this market. Opportunities are related to the extension of applications of biochips in fields with fast development, such as agriculture, forensic sciences, and environmental monitoring, coupled with the continuous development of biochip technology.

Biochips Market Trends:

Technological advancements and innovations

The market is propelled by the rapid progress in technology and periodic modifications of biochip technologies. Biochips are transforming, such as the next-generation sequencing (NGS), lab-on-a-chip, and microarray technologies that improve the power and effective performance of biochips. Further, the advent of biochip-based solutions that are integrated with artificial intelligence (AI) and machine learning (ML) algorithms is amplifying precision medicine, drug discovery, and diagnostic-related applications. Biochips are becoming essential tools as they change to greater sensitivity, accuracy, and miniaturization in genomics, proteomics, and other molecular biology fields, which is enhancing biochips market value. Additionally, ongoing initiatives being taken by the prominent industry players in terms of R&D to launch advanced biochip products and solutions that could respond effectively to emerging requirements from healthcare and biotechnology verticals further fuel market expansion.

Growing demand for personalized medicine

The increasing demand for personalized medicine also significantly fuels the market. Personalized medicine as a practice based on individual profiling of patients by genetic, environmental, and lifestyle factors in tailoring treatment plans is accelerating the need for technologies related to biochips. In addition, the requirement for advanced diagnostic tools such as biochips is growing with the healthcare sector rapidly shifting towards personalized and preventive medicine. This trend can be supported by an increase in the incidence of chronic diseases such as cancer and cardiovascular disorders, which need detailed molecular insight for effective management. Thus, due to the growing scope of personalized medicine, biochips continue to get greater acceptance in clinical and research settings which is further creating a positive biochips market outlook.

Increasing investment in genomics and proteomics research

One of the key drivers for the global market of biochips is increasing investments in genome and proteome research. All governments, academic institutions, and private sectors are investing in genomic as well as proteomic studies, to understand complex biological systems and devise innovative health solutions. Biochips find large applications since they permit high-throughput analysis and large-scale studies of various interactions, such as genetically or proteomically. In addition, the growing applications in precision agriculture, forensic sciences, and environmental monitoring, among others, where high-throughput molecular analyses are required. Moreover, the demand for sophisticated biochip platforms is rising as globally growing funding and collaborative research continue to broaden the scope of this market, thus directing it to foster ongoing new life sciences research.

Biochips Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biochips market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, fabrication technique, analysis method, application, and end user.

Breakup by Product Type:

DNA Chip

Protein Chip

Lab-On-a-Chip

Enzyme Chip

DNA Chip represents the largest market segment

The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.

DNA chips, otherwise called DNA microarrays, are currently the largest product type in the market. This can be supported by the wide application spectrum and technological advances. These chips facilitate large-scale analyses of genetic information; such chips become core tools in genomics, diagnostics, and personalized medicine. Thousands of genes can be analyzed simultaneously, hence making landmark changes in research related to cancer genomics, genetic disorder screening, and pharmacogenomics. It is resulting in more sensitive, specific, and efficient DNA chips with upgraded technologies, thereby increasing adoption. According to the biochips market report, the growing interest in precision medicine and health treatments by individual genomics also accelerates the demand for DNA chips. Key players in the marketplace are engaged in extensive research and development to come up with new products in DNA chips, thereby helping the changing requirements of healthcare and biotech companies. Apart from this, increasing incidences of genetic disorders and chronic diseases require detailed genetic profiling, and thus, DNA chips assume a significant role in contemporary diagnostics and therapy. DNA chips, therefore, hold a greater share in the biochips market since they represent a vital constituent in promoting molecular biology and individualistic healthcare solutions.

Breakup by Fabrication Technique:

Microarray

Microfluidic

Microarray represents the largest market segment

A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.

Microarray technology is the most widely used fabrication technique in this market due to its versatility and efficiency for different applications. This method permits large amounts of biological data to be analyzed at the same time and is used in genomics, transcriptomics, and proteomic studies. The biochips market forecast suggests that quantification of gene or protein expression across the spectrum in a single experiment is game-changing for drug discovery, disease diagnosis, and personalized medicine. New microarray technologies support more accurate, faster, and scaled-up biochip fabrication to enable reliable detection over large fractions of the corresponding user population. Microarray technology is widely used in the healthcare and bioinformatics sectors to improve research activities, as well as help introduce new targeted therapies. Additionally, their integration with modern data analysis techniques and bioinformatics platforms is further expanding the use of microarrays for understanding complex biological processes. With the growth of personalized medicine, the coming years will see a great increase in demand for accurate and high-throughput analytical platforms such as microarrays. Hence, microarray technology continues to be the leading method of manufacturing in the marketplace and plays a foundational role in propelling biomedical research forward as well as improving clinical diagnostics.

Breakup by Analysis Method:

Electrophoresis

Luminescence

Mass Spectrometry

Electrical Signals

Magnetism

Electrophoresis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.

Electrophoresis is the most dominant method of analysis in biochips due to its wide applicability, strength, and precision in separation techniques, and the analysis of biological molecules. This also represents a vital technique in functional genomics, proteomics, and molecular biology through the effective separation of DNA, RNA, and proteins, based on size and charge, offering a view into their structure and function. According to the biochips market overview, electrophoresis is being utilized in several research and routine laboratories, especially in tasks related to genetic mapping, disease diagnosis, and forensic analysis. This, in addition to being a robust and accurate system, permitted working in unison with advanced biochip technologies to ensure better resolution and higher throughput of molecular analyses. Electrophoresis techniques, including capillary and microfluidic electrophoresis, have recently been innovated to further enhance its operations, moving faster and offering more detailed examinations. Evident through the increasing need for high-precision analytical tools within the fields of personalized medicine and biotechnology, electrophoresis is set to remain prominent. Moreover, it consolidates a central position as the leading analysis method in the market with the escalating complex biological systems and disease mechanisms.

Breakup by Application:

Molecular Analysis

Hybridization

Protein

Immunological

Biomolecules

Biomarker

Others

Diagnosis

Gene Diagnosis

Oncology

Inflammatory

Others

Non-Biological Usage

Diagnosis represents the largest market segment

A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis accounted for the largest market share.

Diagnosis is the largest application in the market as an accurate, fast, and comprehensive diagnostic tool is necessary in healthcare. Biochips are revolutionizing the concept of diagnosis in that they can analyze multiple biomarkers in a single chip, helping in the early and accurate detection of diseases. Therefore, this is escalating the biochips demand. This is important in managing chronic and infectious diseases, such as cancer, cardiovascular disorders, and emerging viral infections. These factors are leading to the integration of biochips in diagnostic platforms, which further resulted in enhanced specificity and sensitivity of tests, thereby leading toward better patient outcomes, based on test results, through timely and targeted interventions. Apart from this, progress in biochip technology in the form of microarrays and lab-on-a-chip systems has made things easier, cost-effective, and more accessible at the diagnostic level. The stakes for diagnostics based on biochips are further raised by the rise of personalized medicine, as these will be able to render analyses of genetic profiles to administer treatments on an individual basis. With the changing landscape of healthcare across the globe toward precision and preventive medicine, the adoption of biochips for diagnostic purposes is gaining considerable ground, which essentially sets this as a cornerstone in modern medical diagnostics and fuels the biochips market growth.

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostics Centers

Academic and Research Institutes

Others

Pharmaceutical and biotechnology companies represent the largest market segment

A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

The largest end users in the biochips industry are pharmaceuticals and biotechnology firms. This can be attributed to their extensive research and development activities and increased demand for new and fresh solutions in drug discovery and development processes. Biochips help these sectors immensely in areas such as high-throughput screening, gene analysis, and biomarker identification for the comprehension of the mechanisms of diseases and the subsequent development of targeted therapies. Additionally, biochip technology makes possible new technologically precise, faster, and less expensive methods that hasten drug development and inform and facilitate the planning of clinical trials, hence putting personalized medicine into action with detailed molecular insight. In regard to this, the heavy investments in biochip technology by the studied firms is to improve efficiency and lower development costs. Moreover, close collaboration between the manufacturers of biochips and pharmaceutical and biotech companies fosters further improved forms of biochips tailored to special research needs. With continued pressure from the rising need for new therapeutics and personalized treatment options, there is a growing reliance on biochips within these industries, and it can create a critical difference in innovating and building a competitive edge to deal with the transforming environment of healthcare.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Spain

Russia

Italy

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Others

Latin America

Mexico

Brazil

Argentina

Others

Middle East and Africa

Turkey

Saudi Arabia

United Arab Emirates

Others

North America leads the market, accounting for the largest biochips market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America represents the largest regional market for biochips.

The North America region is the largest contributor to the biochips market due to high-quality healthcare infrastructure and substantial investments in biotechnology research, followed by Asia-Pacific being robustly driven by technological innovation. Besides, the sovereignty of this region is also driven by some major market players in biotech, such as Samsung Biologics and Celltrion, along with comprehensive government support for R&D activities. Along with this, rising chronic diseases and personalized medicine requirements are further fueling a rise in the usage of biochip technologies. Prospective growth opportunities for this market in major countries such as the U.S. and Canada are propelling regional expansion due to genomics and proteomics research grants which are augmenting the biochips market revenue. In addition, the presence of mature pharmaceutical and biotechnology industries in North America allows expeditious commercialization and adoption of biochip applications across diverse healthcare settings.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biochips industry include:

Agilent Technologies, Inc.

bioMerieux SA

Bio-RAD Laboratories, Inc.

CapitalBio Corporation

Dynamic Biosensors GmbH

EMD Millipore Corporation

Fluidigm Corporation

Illumina, Inc.

Perkinelmer, Inc.

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The leading biochips companies are engaged in research and development with respect to new products and technological innovations to enhance the existing technology. Major companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies execute next-generation sequencing and lab-on-chip systems. This develops sensitivity, accuracy, and throughput, hence meeting demand for precise diagnostic and research tools. Such strategic collaborations, mergers, and acquisitions often allow these firms to develop their product line and increase their geographical presence. They are also integrating the biochip technology with artificial intelligence and machine learning, which enhances the data analysis capability. These major players, therefore, meet changing requirements in personalized medicine, diagnostics, and drug discovery, hence maintaining a competitive edge and accelerating the market growth.

Biochips Market News:

September 4, 2023: Agilent and ACTRIS announced their collaboration to expedite cellular and genetic treatment in Singapore. The new partnership intends to install and operate Agilent's xCELLigence real-time cell analyzer, Seahorse XF technology, and other cell analysis portfolio in the country's largest national cell and gene therapy process development and manufacturing facility at ACTRIS.

August 17, 2023: Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the opening of a new office as well as a state-of-the-art Illumina Solutions Center (ISC) to support the growing customer base in Bengaluru.

Key Questions Answered in This Report:

  • How has the global biochips market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biochips market?
  • What is the impact of each driver, restraint, and opportunity on the global biochips market?
  • What are the key regional markets?
  • Which countries represent the most attractive biochips market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the biochips market?
  • What is the breakup of the market based on the fabrication technique?
  • Which is the most attractive fabrication technique in the biochips market?
  • What is the breakup of the market based on the analysis method?
  • Which is the most attractive analysis method in the biochips market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biochips market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biochips market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biochips market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2023
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2023
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Biochips (DNA Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biochips (DNA Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biochips (Protein Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biochips (Protein Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biochips (Lab-On-a-Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biochips (Lab-On-a-Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biochips (Enzyme Chip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biochips (Enzyme Chip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biochips (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biochips (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biochips (Microfluidic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biochips (Microfluidic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biochips (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biochips (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biochips (Luminescence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biochips (Luminescence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biochips (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biochips (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biochips (Electrical Signals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biochips (Electrical Signals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biochips (Magnetism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biochips (Magnetism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biochips (Molecular Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biochips (Molecular Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biochips (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biochips (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biochips (Protein) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biochips (Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biochips (Immunological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biochips (Immunological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biochips (Biomolecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biochips (Biomolecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Biochips (Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Biochips (Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Biochips (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Biochips (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Biochips (Gene Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Biochips (Gene Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Biochips (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Biochips (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Biochips (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Biochips (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Biochips (Non-Biological Usage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Biochips (Non-Biological Usage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Biochips (Hospitals and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Biochips (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Global: Biochips (Academic & Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Global: Biochips (Academic & Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Global: Biochips (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: North America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United States: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Canada: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Spain: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Russia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Italy: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: China: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: India: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Japan: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Australia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 110: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 120: Others: Biochips Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million US$), 2024-2032
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million US$), 2024-2032
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players